Delivery Order SPE2DB22D3501-SPE2DB25FVW60
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,479.42 to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a joint care injection medication. This firm fixed-price contract, awarded on September 17, 2025, with an ultimate completion date of September 18, 2025, represents a non-competitive delivery order executed under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,012.91 on August 8, 2025, for the supply of Synvisc-One Syringe 6ML, a pharmaceutical product for joint pain management. This is a firm fixed price contract with no set-aside designation, competitively awarded under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The delivery order is scheduled for completion by August 11, 2025, with performance based in...
- The Defense Logistics Agency awarded a delivery order valued at $16,710.14 to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a hyaluronic acid-based injection used for osteoarthritis pain management. The contract, issued on December 2, 2025, with completion scheduled for December 3, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The place of performance is listed as AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $7,898.36 delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for Synvisc-One syringes (6mL), with completion targeted for September 9, 2025. This firm fixed-price, non-set-aside contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $30,759.28 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Synvisc-One syringes (6 milliliters, 1 pack) with an ultimate completion date of November 19, 2025. This is a non-set-aside, competitively awarded contract supporting the federal medical supply chain. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and veteran healthcare systems through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $12,611.11 by the Defense Logistics Agency on October 29, 2025, for the supply of Synvisc-One Syringe 6ML. This is a firm fixed price, non-set-aside contract with an ultimate completion date of October 30, 2025. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $13,303.62 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Synvisc-One syringes (6mL) on September 15, 2025, with an ultimate completion date of September 16, 2025. The award, which carries no set-aside designation, represents a competitive procurement fulfilled by the pharmaceutical distributor from its Conshohocken, Pennsylvania corporate office. This delivery order is issued under AmerisourceBergen's broader Indefinite...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $4,843.44 by the Defense Logistics Agency on December 9, 2025, with an ultimate completion date of December 10, 2025. The contract, issued under firm fixed pricing with no set-aside designation, covers the delivery of Synvisc-One Syringe 6ml, a hyaluronic acid-based injectable used for osteoarthritis treatment. The place of performance is located...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $10,137.85 to supply Synvisc-One Syringe 6ML, with an ultimate completion date of December 5, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that serves...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $12,194.04 on November 6, 2025, for the supply of Synvisc-One Syringe 6ML, a viscosupplementation medication used in joint pain management. This firm fixed-price delivery order, with an ultimate completion date of November 7, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract was competitively awarded with no...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FVW60Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $30,813.16 to AmerisourceBergen Drug Corp for Synvisc-One Syringe 6ML, a pharmaceutical product for joint pain management. This firm fixed-price delivery order was competitively awarded without set-aside designation and is scheduled for completion by June 2, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters and primary operations supporting federal medical procurement. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion comprehensive pharmaceutical support vehicle running through December 2026. As a major pharmaceutical distributor serving military and veteran healthcare systems, AmerisourceBergen maintains extensive federal contracting capabilities across multiple therapeutic domains. The underlying IDC enables the company to supply brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.8k | 5/30/25 |